Crossmark

Lymphatic filariasis control in Tanzania: infection, disease perceptions and drug uptake patterns in an endemic community after multiple rounds of mass drug administration

Crossref DOI link: https://doi.org/10.1186/s13071-018-2999-x

Published Online: 2018-07-20

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Derua, Yahya A.

Kisinza, William N.

Simonsen, Paul E.
Funding

Funding for this research was provided by:

Danida Research Council (09-096LIFE)

DBL-Centre for Health Research and Development, University of Copenhagen
License Information

Text and Data Mining valid from 2018-07-20
More Information

Article History

Received: 5 June 2018

Accepted: 6 July 2018

First Online: 20 July 2018

Ethics approval and consent to participate

: Before the start of the study, meetings were held in the three study villages to inform the inhabitants on the purpose of the study and to obtain their cooperation. Prior to the interviews, oral informed consent was sought and obtained from all adults, and from parents or guardians of individuals less than 18 years-old. Ethical approval for the study was provided by the Medical Research Coordinating Committee of the National Institute for Medical Research, Tanzania for a large study monitoring LF control in Tanga Region, Tanzania (NIMR/HQ/R.8a/Vol.IX/1044). This article is published with permission from the director of the Tanzanian National Institute for Medical Research.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below